REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Healthcare, financials stocks drag FTSE 100 lower; DS Smith outperforms

Tue, 07th Sep 2021 09:28

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Broker TP ICAP slips as first-half profit falls

* UK PM raises taxes to tackle health crisis

* 888 in talks to buy William Hill's non-U.S. assets; shares
down

* FTSE 100 down 0.5%, FTSE 250 off 0.6%
(Updates to close)

By Devik Jain and Amal S

Sept 7 (Reuters) - London's FTSE 100 index ended lower on
Tuesday, weighed down by healthcare stocks and brokerages, while
DS Smith jumped to the top of the index after an upbeat trading
update.

The blue-chip index fell 0.5% and marked its worst
session in nearly three weeks, as healthcare
weighed with drugmakers AstraZeneca and GlaxoSmithKline
among top drags.

Investment banking and brokerage services providers
shed 1% after TP ICAP Group Plc reported a lower
half-year profit.. Shares of the world's largest
inter-dealer broker slipped 10.7%.

DS Smith jumped 2.8% to the top of the index as
J.P. Morgan raised its price target on the cardboard maker's
stock after it said trading continued to progress well in line
with the trends.

European stocks edged down as investors awaited the European
Central Bank's policy meeting on Thursday for clues on how the
crisis-fighting measures would be dismantled.

"After a weak US jobs report last Friday prompted
speculation the Federal Reserve would hold off on tapering
support for the economy, attention will switch to the European
Central Bank this week as it unveils its latest decision on
monetary policy on Thursday," said Russ Mould, investment
director at AJ Bell.

Meanwhile, British Prime Minister Boris Johnson set out
plans to raise taxes on workers, employers and some investors to
try to fix a health and social care funding crisis sending pound
down.

The domestically focused mid-cap FTSE 250 index was
down 0.6% dragged by industrial stocks.

Among individual stocks, 888 fell 1.8% after the
British gambling group said it was in advanced talks with
Caesars Entertainment for a possible acquisition of the
international operations of the U.S. company's William Hill
business.

Meggitt Plc fell 12.1% to the bottom of mid-cap
index after aerospace parts maker TransDigm bowed out of
an $8.7 billion takeover battle with fellow U.S. bidder
Parker-Hannifin for the British engineering firm.
(Reporting by Devik Jain and Amal S in Bengaluru; Editing by
Saumyadeb Chakrabarty and Uttaresh.V, Editing by William
Maclean)

More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.